Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Kezar Life Sciences (KZR) Return on Equity (2021 - 2025)

Kezar Life Sciences' Return on Equity history spans 5 years, with the latest figure at 0.7% for Q3 2025.

  • For Q3 2025, Return on Equity fell 3.0% year-over-year to 0.7%; the TTM value through Sep 2025 reached 0.7%, down 3.0%, while the annual FY2024 figure was 0.55%, 10.0% down from the prior year.
  • Return on Equity for Q3 2025 was 0.7% at Kezar Life Sciences, up from 0.73% in the prior quarter.
  • Across five years, Return on Equity topped out at 0.22% in Q3 2022 and bottomed at 0.73% in Q2 2025.
  • The 5-year median for Return on Equity is 0.45% (2023), against an average of 0.47%.
  • The largest annual shift saw Return on Equity grew 10bps in 2022 before it dropped -28bps in 2024.
  • A 5-year view of Return on Equity shows it stood at 0.35% in 2021, then grew by 29bps to 0.25% in 2022, then crashed by -105bps to 0.5% in 2023, then tumbled by -32bps to 0.67% in 2024, then dropped by -5bps to 0.7% in 2025.
  • Per Business Quant, the three most recent readings for KZR's Return on Equity are 0.7% (Q3 2025), 0.73% (Q2 2025), and 0.71% (Q1 2025).